🔗 Permalink

Inventor profile of:

John Dick

City:

Toronto

Country:

Canada

Published Applications:

14

Last publication date:

2026-06-04

Top Assignees for applications by John Dick

The entities that hold a legal rights for patent applications filed by inventor Dick John:

UNIVERSITY HEALTH NETWORK 5 Toronto, Canada
Institut National De La Sante Et De La Recherche Medicale (INSERM) 2 Paris, France
UNIVERSITY HEALTH NETWORK 2 Toronto, ON Canada
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 1 Boston, MA United States
The Hospital for Sick Children 1 Toronto, Canada
UNIVERSITY HEALTH NETWORK 1 Toronto, CA United States
THE HOSPITAL FOR SICK CHILDREN 1 Toronto, ON United States
THE HOSPITAL FOR SICK CHILDREN 1 Toronto, ON Canada

Recent patent applications by Dick John

John Dick from Toronto, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-04

US20260152800A1

Chemistry; metallurgy

BIOMARKER BASED DIAGNOSIS AND TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS

#2 | 2025-08-14

US20250257408A1

Chemistry; metallurgy

CLONAL HEMATOPOIESIS AS A BIOMARKER

#3 | 2024-03-14

US20240084399A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL CANCERS TARGETING THE SIRPALPHA - CD47 INTERACTION

#4 | 2019-10-03

US20190300956A1

Chemistry; metallurgy

Method for identifying high-risk AML patients

#5 | 2019-05-09

US20190136188A1

Chemistry; metallurgy

4HPR AND ITS USE IN THE CULTURING OF HEMATOPOIETIC STEM CELLS

#6 | 2019-03-28

US20190093174A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL CANCERS TARGETING THE SIRPALPHA CD47 INTERACTION

#7 | 2014-08-28

US20140242095A1

Chemistry; metallurgy

ANTIBODIES AND ANTIBODY FRAGMENTS TARGETING SIRP-ALPHA AND THEIR USE IN TREATING HEMATOLOGIC CANCERS

#8 | 2012-10-04

US20120252060A1

Chemistry; metallurgy

Self-Renewing Single Human Hematopoietic Stem Cells, an Early Lymphoid Progenitor and Methods of Enriching the Same

#9 | 2012-09-20

US20120237488A1

Chemistry; metallurgy

LSC AND HSC SIGNATURES FOR PREDICTING SURVIVAL OF PATIENTS HAVING HEMATOLOGICAL CANCER

#10 | 2012-07-26

US20120189625A1

Chemistry; metallurgy

Compositions and methods for treating hematological cancers targeting the SIRPα CD47 interaction

#11 | 2011-12-01

US20110294692A1

Chemistry; metallurgy

USE OF MIR-126 FOR ENHANCING HEMATOPOIETIC STEM CELL ENGRAFTMENT, FOR ISOLATING HEMATOPOIETIC STEM CELLS, AND FOR TREATING AND MONITORING THE TREATMENT OF ACUTE MYELOID LEUKEMIA

#12 | 2010-02-18

US20100040540A1

Chemistry; metallurgy

ANTI CD44 ANTIBODIES FOR ERADICATING LEUKAEMIC STEM CELLS AND BREAST CANCER STEM CELLS

#13 | 2007-08-09

US20070184051A1

Chemistry; metallurgy

Anti CD44 antibodies for eradicating stem cells

#14 | 2005-07-07

US20050147606A1

Chemistry; metallurgy

Anti CD44 antibodies for eradicating stem cells

InventorID:

888171 ⎘